BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32373264)

  • 1. Temporal trend of measles cases and impact of vaccination on mortality in Jigawa State, Nigeria, 2013-2017: a secondary data analysis.
    Faruk AS; Adebowale AS; Balogun MS; Taiwo L; Adeoye O; Mamuda S; Waziri NE
    Pan Afr Med J; 2020; 35(Suppl 1):13. PubMed ID: 32373264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in measles cases in Bayelsa state, Nigeria: a five-year review of case-based surveillance data (2014-2018).
    Aworabhi-Oki N; Numbere T; Balogun MS; Usman A; Utulu R; Ebere N; Omubo W; Stow J; Abba S; Olorukooba A
    BMC Public Health; 2020 Jun; 20(1):938. PubMed ID: 32539691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Descriptive epidemiology of measles cases in Bauchi State, 2013-2018.
    Ori PU; Adebowale A; Umeokonkwo CD; Osigwe U; Balogun MS
    BMC Public Health; 2021 Jul; 21(1):1311. PubMed ID: 34225675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of declining vaccination coverage on measles control: a case study of Abia state Nigeria.
    Umeh CA; Ahaneku HP
    Pan Afr Med J; 2013; 15():105. PubMed ID: 24244791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of measles in Oromia region, Ethiopia, 2007-2016.
    Gutu MA; Bekele A; Seid Y; Woyessa AB
    Pan Afr Med J; 2020; 37():171. PubMed ID: 33447326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measles outbreak investigation in Guji zone of Oromia Region, Ethiopia.
    Belda K; Tegegne AA; Mersha AM; Bayenessagne MG; Hussein I; Bezabeh B
    Pan Afr Med J; 2017; 27(Suppl 2):9. PubMed ID: 28983397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measles outbreak investigation in Ginnir district of Bale zone, Oromia region, Southeast Ethiopia, May 2019.
    Kalil FS; Gemeda DH; Bedaso MH; Wario SK
    Pan Afr Med J; 2020; 36():20. PubMed ID: 32774597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Burden of measles in Nigeria: a five-year review of casebased surveillance data, 2012-2016.
    Ibrahim BS; Usman R; Mohammed Y; Datti Z; Okunromade O; Abubakar AA; Nguku PM
    Pan Afr Med J; 2019; 32(Suppl 1):5. PubMed ID: 30984326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in measles incidence and measles vaccination coverage in Nigeria, 2008-2018.
    Jean Baptiste AE; Masresha B; Wagai J; Luce R; Oteri J; Dieng B; Bawa S; Ikeonu OC; Chukwuji M; Braka F; Sanders EAM; Hahné S; Hak E
    Vaccine; 2021 Nov; 39 Suppl 3():C89-C95. PubMed ID: 33875267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measles resurgence following a nationwide measles vaccination campaign in Nigeria, 2005-2008.
    Weldegebriel GG; Gasasira A; Harvey P; Masresha B; Goodson JL; Pate MA; Abanida E; Chevez A
    J Infect Dis; 2011 Jul; 204 Suppl 1():S226-31. PubMed ID: 21666165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Geographical and time trends of measles incidence and measles vaccination coverage and their correlation in Nigeria.
    Sato R; Makinde OA; Daam KC; Lawal B
    Hum Vaccin Immunother; 2022 Nov; 18(6):2114697. PubMed ID: 36041074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measles resurgence in southern Africa: challenges to measles elimination.
    Shibeshi ME; Masresha BG; Smit SB; Biellik RJ; Nicholson JL; Muitherero C; Shivute N; Walker O; Reggis K; Goodson JL
    Vaccine; 2014 Apr; 32(16):1798-807. PubMed ID: 24530936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress towards measles elimination in Eritrea: 2003 - 2018.
    Yehdego T; Yhdego TK; Masresha B; Gebreslassie A; Katsande R; Fussum D; Lebo E; Namboze J
    Pan Afr Med J; 2020; 35(Suppl 1):7. PubMed ID: 32373258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measles outbreaks and Supplemental Immunization Activities (SIAs): the Gwagwalada experience, Abuja 2015.
    Olugbade OT; Adeyemi AS; Adeoti AH; Ilesanmi OS; Gidado SO; Waziri NE; Aworh MK
    Pan Afr Med J; 2019; 32(Suppl 1):10. PubMed ID: 30949285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of low measles vaccination coverage in children living in an endemic area.
    Lo Vecchio A; Cambriglia MD; Fedele MC; Basile FW; Chiatto F; Miraglia Del Giudice M; Guarino A
    Eur J Pediatr; 2019 Feb; 178(2):243-251. PubMed ID: 30430239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measles in Europe: an epidemiological assessment.
    Muscat M; Bang H; Wohlfahrt J; Glismann S; Mølbak K;
    Lancet; 2009 Jan; 373(9661):383-9. PubMed ID: 19131097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second-dose measles vaccination and associated factors among under-five children in urban areas of North Shoa Zone, Central Ethiopia, 2022.
    Tadesse AW; Sahlu D; Benayew M
    Front Public Health; 2022; 10():1029740. PubMed ID: 36568740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measles in Europe in 2001-2002.
    Muscat M; Glismann S; Bang H
    Euro Surveill; 2003 Jun; 8(6):123-9. PubMed ID: 12878801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inequalities in measles immunization coverage in Ethiopia: a cross-sectional analysis of demographic and health surveys 2000-2016.
    Shibre G; Zegeye B; Idriss-Wheeler D; Yaya S
    BMC Infect Dis; 2020 Jul; 20(1):481. PubMed ID: 32635891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of measles cases, vaccine effectiveness, and performance towards measles elimination in The Gambia.
    Sowe A; Njie M; Sowe D; Fofana S; Ceesay L; Camara Y; Tesfaye B; Bah S; Bah AK; Baldeh AK; Dampha BD; Baldeh SN; Touray A
    PLoS One; 2021; 16(10):e0258961. PubMed ID: 34673828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.